Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections

Vaborbactam is a novel boron-based beta-lactamase inhibitor developed to be effective against Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. This enzyme is a key driver in the global spread of β-lactam resistance among carbapenem-resistant Enterobacterales. Alone, vaborbactam has no a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhowmick, Tanaya, Weinstein, Melvin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680474/
https://www.ncbi.nlm.nih.gov/pubmed/33017041
http://dx.doi.org/10.1007/s40121-020-00350-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680474/
https://www.ncbi.nlm.nih.gov/pubmed/33017041
http://dx.doi.org/10.1007/s40121-020-00350-1

Ejemplares similares